Are You Overlooking the “X Factor” in Biopharma M&A?
Add bookmark
JLL shares three strategies to use corporate real estate to increase returns during a merger or acquisition
When Merck acquired Schering-Plough in 2009, the corporate real estate team reduced the combined companies’ occupancy costs by $300 million within three years—making a significant contribution to the $3.5 billion merger synergy goal. For Merck, the value hidden within the corporate real estate portfolio was the “X factor” that contributed to the transaction'...
